Prior to large trial, we will conduct a pilot trial comparing compare arthroscopic capsuloligamentous repair vs. coracoid transfer (Latarjet procedure) on recurrent dislocation rates and functional outcomes over a 24-month period.Primary questionsWe…
ID
Source
Brief title
Condition
- Joint disorders
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary outcome of the pilot study will be a composite measure of
feasibility, including:
1) Recruitment (number of patients recruited at each site during a 10-month
period),
2) Protocol adherence (number of errors in randomization); and
3) Follow-up (proportion of participants followed at two years).
We hypothesize that our feasibility outcomes will meet a priori criteria
The success of the pilot study will be based upon the following a priori
thresholds:
1) 82 patients recruited within 10 months,
2) 3 or fewer errors in randomization across the 82 enrolled patients and
treatment adherence in a minimum 66 of 82 participants (80%), and
3) 70 of 82 participants (85%) achieving complete follow-up at two years.
Secondary outcome
Secondary objectives are to evaluate:
1) Rate of recurrent dislocation and symptomatic instability between patients
randomized to (capsuloligamentous repair +/- remplissage) and those receiving
open Latarjet procedure. This outcome is critically patient important and is
objectively documented in the case of shoulder dislocation or in the case of
recurrent symptomatic instability will be patient reported at follow up.
2) Clinical outcomes measured by Western Ontario Shoulder Instability (WOSI)
Index, American Shoulder and Elbow Society (ASES) score, Patient Satisfaction
Scale, Shoulder Activity Scale and EQ-5D;,
The WOSI is a self-administered quality of life outcome measure designed for
clinical trials evaluating treatments for patients with shoulder instability.
It has been shown to have high reliability, validity and responsiveness31. The
WOSI score is commonly utilized and has been shown to provide excellent ability
to detect variability in severity of post-operative instability symptoms
including following shoulder stabilization procedures30.
The ASES score is designed to assess shoulder function including instability29.
It allows for patient self-evaluation through 11 items that can be used to
generate a score, divided into 2 areas: pain (1 item) and function (10 items).
Functional outcome assessment will be patient reported on paper through
post-operative follow up forms administered by the study coordinator or
designate at each site.
3) Physical examination: range of motion, strength, stability;
Physical examination following surgery will be performed by the operating
surgeon and will consist of functional assessment important to patients. Range
of motion and strength as well as assessment of shoulder stability are commonly
reported outcome measures in the literature when assessing success following
shoulder instability surgery1,38. Range of motion will be assessed in forward
flexion, abduction, external rotation and internal rotation.
Strength will be assessed on a five-point scale 0/5: no contraction, 1/5:
muscle flicker, but no movement, 2/5: movement possible, but not against
gravity (test the joint in its horizontal plane), 3/5: movement possible
against gravity, but not against resistance by the examiner, 4/5: movement
possible against some resistance by the examiner and 5/5: normal strength.
Stability will be assessed primarily via the apprehension- relocation physical
examination maneuver which has demonstrated the highest sensitivity in the
literature for the diagnosis of anterior instability.
4) Return to previous level of activity and sport
The majority of shoulder instability affects young individuals involved in
athletic activities and sport. An important aspect in the success of surgical
intervention is to return patients back to previous and desired level of
activity6. This outcome will be patient reported at follow up.
5) Rate of major and minor shoulder-related complications and serious adverse
events
Major complications will include, symptomatic non-union of transferred bone
block, hardware penetration into the joint, neurological or vascular injury or
deep vein thrombosis.
Background summary
The shoulder is the most commonly dislocated joint in the body with a global
incidence that ranges from 15.3 to 24.8 per 100 000 people. A review of
shoulder reductions performed in emergency rooms in Ontario, Canada between
2002 and 2010 identified 20,719 dislocations affecting primarily young patients
with a median age of 35 years and 74% male. Anterior dislocations, the most
common type of shoulder dislocation, are often complicated by subsequent
instability, and recurrent dislocation, with reported rates as high as 42% and
primarily affecting young males. Shoulder instability commonly results in pain
and negatively impacts quality of life.
During the process of a shoulder dislocation the anterior labrum attachment to
the glenoid is commonly avulsed in what is known as a Bankart lesion. With
recurrent dislocations there may be attrition of the labrum and progressive
loss of the anterior bony contour of the glenoid. In instances where bone loss
is not present the labrum is reattached to the glenoid in what is known as a
Bankart repair which is commonly performed via open or arthroscopic means.
Instances of significant bone loss (>25%) are commonly treated with a bone
transfer known as a *Latarjet* procedure. There is controversy however
regarding the optimal treatment of patients with some mild degree of bone loss.
Study objective
Prior to large trial, we will conduct a pilot trial comparing compare
arthroscopic capsuloligamentous repair vs. coracoid transfer (Latarjet
procedure) on recurrent dislocation rates and functional outcomes over a
24-month period.
Primary questions
We aim to examine in a pilot RCT, the feasibility of a larger trial.
Feasibility objectives include:
1. Ability to recruit patients across clinical sites
2. Adherence to the study protocol; and
3. Ability to follow patients to 24 months
Secondary questions
Our trial will compare arthroscopic capsuloligamentous repair vs. coracoid
transfer (Latarjet procedure) on:
1. Rates of recurrent shoulder dislocations and symptoms of instability up to
24 months* post- surgery;
2. Clinical outcomes measured by Western Ontario Shoulder Instability (WOSI)
Index, American Shoulder and Elbow Society (ASES) score, Shoulder Activity
Scale and EQ-5D and Patient Satisfaction Scale;
3. Physical examination: range of motion, strength, stability;
4. Return to previous level of activity;
5. Rate of shoulder-related complications and serious adverse events.
Study design
We propose a multi-centre pilot RCT of 82 patients across Canada, United States
and/or Europe to compare the effect of capsuloligamentous repair (Bankart
procedure+ Remplissage) and coracoid transfer (Latarjet procedure) in patients
with post-traumatic recurrent anterior dislocation. Eligible and consenting
participants will be followed-up by the site for 24 months. Outcomes will be
assessed at 2 weeks, 3 months, 6 months, 12 months, and 24 months post-surgery.
Intervention
Participants will undergo arthroscopic stabilization (capsuloligamentous repair
+/- remplissage) or open or arthroscopic Latarjet procedure according to
standard procedure.
Study burden and risks
Both the intervention and the control treatment as well as the x-ray taken
after Latarjet procedure are standard care, therefore not associated with
additional risks.
Charlton Avenue E 50
Hamilton, Canada L8N 4A6
CA
Charlton Avenue E 50
Hamilton, Canada L8N 4A6
CA
Listed location countries
Age
Inclusion criteria
1. Men and women ages 18-50 years;
2. Diagnosis of post-traumatic recurrent anterior dislocation. This will
require a minimum of 2 episodes of documented dislocations either by
radiographic evidence or documented reduction of anterior shoulder dislocation
as well as physical examination eliciting unwanted glenohumeral translation
with reproduction of symptoms;
3. Mild glenoid bone loss as defined on CT by standardized and reproducible
best-fit circle technique (>10% but <20%);
4. Provision of informed consent.
Exclusion criteria
1. Patients with concomitant injuries (cuff tear);
2. Previous shoulder surgery;
3. Patients that will likely have problems, in the judgment of the
investigators, with maintaining follow-up;
4. Epilepsy;
5. Patients who are or at risk of being incarcerated;
6. Diagnosis of multidirectional instability;
7. Cases involving litigation or workplace insurance claims (e.g. WSIB);
8. Confirmed connective tissue disorder (Ehlers-Danlos, Marfans) or Beighton
hypermobility score >6.
9. Pregnancy.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
ClinicalTrials.gov | NCT03585491 |
CCMO | NL76934.075.21 |